Ontera Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 8

Ontera General Information

Description

Operator of a healthcare information platform intended to focus on topics related to biology, science, and health. The company's platform provides information and knowledge about interesting biological processes, medical research, and health knowledge, enabling users to keep updated about useful information to take care of their health.

Contact Information

Website
www.ontera.bio
Formerly Known As
Two Pore Guys
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2827 Rama IV Rd, Khwaeng Khlong Tan
  • Khet Khlong Toei, Krung Thep Maha Nakhon
  • Bangkok, 10110
  • Thailand
+66 02
Primary Industry
Other Healthcare Services
Other Industries
Other Services (B2C Non-Financial)
Information Services (B2C)
Corporate Office
  • 2827 Rama IV Rd, Khwaeng Khlong Tan
  • Khet Khlong Toei, Krung Thep Maha Nakhon
  • Bangkok, 10110
  • Thailand
+66 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ontera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Secondary Transaction - Private 21-Jun-2023 Completed Generating Revenue
9. Later Stage VC (Series B1) 05-Aug-2020 Completed Generating Revenue
8. Debt - PPP 10-Apr-2020 Completed Product Development
7. Grant 19-Nov-2018 Completed Product Development
6. Later Stage VC (Series A2) 20-Sep-2018 Completed Product Development
5. Later Stage VC (Series A1) 22-Jun-2018 Completed Product Development
4. Later Stage VC (Series A) 25-Apr-2017 Completed Product Development
3. Seed Round 05-Jul-2016 Completed Startup
2. Grant 01-Jan-2013 $150K Completed Startup
1. University Spin-Out 01-Aug-2011 Completed Startup
To view Ontera’s complete valuation and funding history, request access »

Ontera Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B3
Series B2
Series B1
Series A2 Prime
Series A1 Prime
Series A-Prime
Series Seed-Prime
Series A2
Series A1 1,574,488 $0.000100 8% $9.53 $9.53 1x $9.53 1.34%
Series A 349,979 $0.000100 8% $27.14 $27.14 1x $7.26 1.11%
To view Ontera’s complete cap table history, request access »

Ontera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a healthcare information platform intended to focus on topics related to biology, science, and health. The c
Other Healthcare Services
Bangkok, Thailand
8 As of 2023

Alameda, CA
 

Brisbane, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ontera Competitors (2)

One of Ontera’s 2 competitors is Alveo (Diagnostic Equipment), a Venture Capital-Backed company based in Alameda, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alveo (Diagnostic Equipment) Venture Capital-Backed Alameda, CA
Mammoth Biosciences Venture Capital-Backed Brisbane, CA
You’re viewing 2 of 2 competitors. Get the full list »

Ontera Patents

Ontera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022061307-A1 Methods for accurate and reproducible detection and quantification of target polynucleotides using a nanopore device Inactive 21-Sep-2020
US-20210299667-A1 Photonic thermocycling devices and methods Inactive 26-Mar-2020
WO-2021195296-A1 Photonic thermocycling devices and methods Inactive 26-Mar-2020
US-20210237079-A1 Device with flow features for sample processing and method of use Inactive 31-Jan-2020
EP-3959331-A1 Multipore determination of fractional abundance of polynucleotide sequences in a sample Inactive 22-Apr-2019 C12Q1/68
To view Ontera’s complete patent history, request access »

Ontera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ontera Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Central Coast Angels Venture Capital Minority
VTC Ventures Venture Capital Minority
Gates Foundation Not-For-Profit Venture Capital
Applied Ventures Corporate Venture Capital Minority
DEFTA Partners Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ontera FAQs

  • When was Ontera founded?

    Ontera was founded in 2011.

  • Where is Ontera headquartered?

    Ontera is headquartered in Bangkok, Thailand.

  • What is the size of Ontera?

    Ontera has 8 total employees.

  • What industry is Ontera in?

    Ontera’s primary industry is Other Healthcare Services.

  • Is Ontera a private or public company?

    Ontera is a Private company.

  • What is Ontera’s current revenue?

    The current revenue for Ontera is .

  • How much funding has Ontera raised over time?

    Ontera has raised $68M.

  • Who are Ontera’s investors?

    Central Coast Angels, VTC Ventures, Gates Foundation, Applied Ventures, and DEFTA Partners are 5 of 8 investors who have invested in Ontera.

  • Who are Ontera’s competitors?

    Alveo (Diagnostic Equipment) and Mammoth Biosciences are competitors of Ontera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process